A detailed history of Wimmer Associates 1, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wimmer Associates 1, LLC holds 3,110 shares of GILD stock, worth $273,928. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,110
Previous 3,110 -0.0%
Holding current value
$273,928
Previous $227,000 6.17%
% of portfolio
0.11%
Previous 0.12%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $4,674 - $6,710
-75 Reduced 2.35%
3,110 $266,000
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $189,634 - $216,611
3,185 New
3,185 $250,000
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $194,900 - $244,231
-3,365 Closed
0 $0
Q4 2021

Feb 16, 2022

SELL
$64.88 - $73.64 $1,946 - $2,209
-30 Reduced 0.88%
3,365 $244,000
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $5,753 - $6,207
-85 Reduced 2.44%
3,395 $237,000
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $44,100 - $50,318
-735 Reduced 17.44%
3,480 $225,000
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $3,682 - $4,195
65 Added 1.57%
4,215 $246,000
Q3 2020

Dec 03, 2020

BUY
$62.1 - $78.08 $13,351 - $16,787
215 Added 5.46%
4,150 $262,000
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $52,446 - $60,900
725 Added 22.59%
3,935 $270,000
Q1 2020

May 15, 2020

SELL
$62.63 - $80.22 $14,718 - $18,851
-235 Reduced 6.82%
3,210 $240,000
Q3 2019

Nov 14, 2019

SELL
$62.51 - $69.0 $9,376 - $10,350
-150 Reduced 4.17%
3,445 $218,000
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $4,540 - $5,925
75 Added 2.13%
3,595 $225,000
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $28,654 - $31,725
-402 Reduced 10.25%
3,520 $272,000
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $4,411 - $5,146
-68 Reduced 1.7%
3,922 $278,000
Q1 2018

May 10, 2018

BUY
$72.84 - $88.8 $9,906 - $12,076
136 Added 3.53%
3,990 $301,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,854
3,854 $273,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Wimmer Associates 1, LLC Portfolio

Follow Wimmer Associates 1, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wimmer Associates 1, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wimmer Associates 1, LLC with notifications on news.